70 related articles for article (PubMed ID: 3703703)
1. The incidence of PUVA lentigines.
Jung EG; Obert W
Photodermatol; 1986 Feb; 3(1):46-7. PubMed ID: 3703703
[No Abstract] [Full Text] [Related]
2. Acral PUVA--induced pigmented macules.
Cruz A; Sánchez JL
Bol Asoc Med P R; 1990 Oct; 82(10):460-2. PubMed ID: 2080960
[TBL] [Abstract][Full Text] [Related]
3. Comparison of therapeutic efficacy of topical PUVA, oral etretinate, and combined PUVA and etretinate for the treatment of psoriasis and development of PUVA lentigines and antinuclear antibodies.
Takashima A; Sunohara A; Matsunami E; Mizuno N
J Dermatol; 1988 Dec; 15(6):473-9. PubMed ID: 3074090
[No Abstract] [Full Text] [Related]
4. PUVA lentigines confined to mycosis fungoides lesions.
Gonzàlez-de Arriba A; Pedraz J; Jones-Caballero M; Nam-Cha T; Fernández-Herrera J; García-Diez A
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):1005-6. PubMed ID: 17659031
[No Abstract] [Full Text] [Related]
5. Comparative morphometric study of eruptive PUVA-induced and chronic sun-induced lentigines of the skin.
Nikkels A; Ben Mosbah T; Piérard-Franchimont C; de la Brassinne M; Piérard GE
Anal Quant Cytol Histol; 1991 Feb; 13(1):23-6. PubMed ID: 2025370
[TBL] [Abstract][Full Text] [Related]
6. [Postphotochemotherapeutic eruptive lentigines].
Kietzmann H; Goos M; Christophers E
Ann Dermatol Venereol; 1983; 110(1):63-7. PubMed ID: 6859755
[No Abstract] [Full Text] [Related]
7. Atypical pigmented lesions following extensive PUVA therapy.
Basarab T; Millard TP; McGregor JM; Barker JN
Clin Exp Dermatol; 2000 Mar; 25(2):135-7. PubMed ID: 10733639
[TBL] [Abstract][Full Text] [Related]
8. Long-term photochemotherapy for psoriasis: a histopathological and clinical follow-up study with special emphasis on tumour incidence and behavior of pigmented lesions.
Ros AM; Wennersten G; Lagerholm B
Acta Derm Venereol; 1983; 63(3):215-21. PubMed ID: 6192634
[TBL] [Abstract][Full Text] [Related]
9. Cryotherapy of PUVA lentigines.
Leroy D; Dompmartin A; Dubreuil A; Louvet S
Br J Dermatol; 1996 Dec; 135(6):988-90. PubMed ID: 8977725
[TBL] [Abstract][Full Text] [Related]
10. The PUVA lentigo: an analysis of predisposing factors.
Rhodes AR; Stern RS; Melski JW
J Invest Dermatol; 1983 Nov; 81(5):459-63. PubMed ID: 6631058
[TBL] [Abstract][Full Text] [Related]
11. PUVA lentigines.
Farr PM; Diffey BL
Photodermatol; 1987 Feb; 4(1):59. PubMed ID: 3615251
[No Abstract] [Full Text] [Related]
12. Multiple lentigines arising in resolving psoriatic plaques after treatment with etanercept.
Costa LA; Belinchón I; Betlloch I; Pérez-Crespo M; Mataix J
Dermatol Online J; 2008 Jan; 14(1):11. PubMed ID: 18319028
[TBL] [Abstract][Full Text] [Related]
13. PUVA-induced melanocytic atypia: is it confined to PUVA lentigines?
Abel EA; Reid H; Wood C; Hu CH
J Am Acad Dermatol; 1985 Nov; 13(5 Pt 1):761-8. PubMed ID: 4078071
[TBL] [Abstract][Full Text] [Related]
14. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
[TBL] [Abstract][Full Text] [Related]
15. Lentigines in psoriatic plaques: are they unique?
Dawn G; McHenry P; Burden AD
Clin Exp Dermatol; 2001 Jul; 26(5):459. PubMed ID: 11488842
[No Abstract] [Full Text] [Related]
16. Long-term safety of trioxsalen bath PUVA treatment: an 8-year follow-up of 149 psoriasis patients.
Berne B; Fischer T; Michaëlsson G; Norén P
Photodermatol; 1984 Feb; 1(1):18-22. PubMed ID: 6531278
[TBL] [Abstract][Full Text] [Related]
17. Multiple lentigines confined to psoriatic plaques.
Burrows NP; Handfield-Jones S; Monk BE; Sabroe RA; Geraghty JM; Norris PG
Clin Exp Dermatol; 1994 Sep; 19(5):380-2. PubMed ID: 7955492
[TBL] [Abstract][Full Text] [Related]
18. Risk of cutaneous carcinoma in psoriatic patients treated with PUVA.
Eskelinen A; Halme K; Lassus A; Idänpään-Heikkilä J
Photodermatol; 1985 Feb; 2(1):10-4. PubMed ID: 3982991
[TBL] [Abstract][Full Text] [Related]
19. Lymphoma risk in psoriasis: results of the PUVA follow-up study.
Stern RS
Arch Dermatol; 2006 Sep; 142(9):1132-5. PubMed ID: 16983000
[TBL] [Abstract][Full Text] [Related]
20. Dermatomyositis occurring during psoralen A (PUVA) therapy.
Sinoway PA; Davidson CL; Callen JP
J Rheumatol; 1994 Feb; 21(2):353-6. PubMed ID: 8182650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
